Established in Shenzhen in 2004 as a wholly-owned subsidiary of Shenzhen Hepalink Pharmaceutical Co., Ltd., Techdow Pharmaceutical is a leading Chinese exporter of enoxaparin sodium APIs and low molecular weight heparin (LMWH) formulations. Techdow’s enoxaparin sodium injection is the first enoxaparin sodium biosimilar approved by the European Medicines Agency (EMA) and the company’s products are currently being sold to over 40 countries and regions, winning recognition and praise from its customers.
Established in 2004
Products being sold to over 40 countries and regions
enoxaparin sodium biosimilar approved by the EMA
and the first generic enoxaparin sodium injection approved by the drug regulator in China
